Sheila Asghar

587 total citations
22 papers, 443 citations indexed

About

Sheila Asghar is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sheila Asghar has authored 22 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 8 papers in Pediatrics, Perinatology and Child Health and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sheila Asghar's work include Bipolar Disorder and Treatment (8 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Advanced MRI Techniques and Applications (5 papers). Sheila Asghar is often cited by papers focused on Bipolar Disorder and Treatment (8 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Advanced MRI Techniques and Applications (5 papers). Sheila Asghar collaborates with scholars based in Canada, United States and Mexico. Sheila Asghar's co-authors include Peter H. Silverstone, Christopher C. Hanstock, Michele Ulrich, Ren Wu, Tina O'Donnell, Glen B. Baker, Emily C. Bell, Morgan Willson, Alan H. Wilman and Sanjay Dave and has published in prestigious journals such as Neurology, Biological Psychiatry and Muscle & Nerve.

In The Last Decade

Sheila Asghar

18 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheila Asghar Canada 12 283 112 82 67 61 22 443
Juliana Usher Germany 12 243 0.9× 54 0.5× 131 1.6× 66 1.0× 47 0.8× 16 364
Helen E. Courvoisie United States 6 204 0.7× 96 0.9× 84 1.0× 46 0.7× 27 0.4× 7 300
Marie Raffin France 16 454 1.6× 116 1.0× 178 2.2× 111 1.7× 19 0.3× 30 766
Joseph M. Bebchuk United States 6 454 1.6× 203 1.8× 76 0.9× 74 1.1× 94 1.5× 12 689
Kristina Hunter United States 10 227 0.8× 50 0.4× 124 1.5× 69 1.0× 31 0.5× 14 413
Nadia Sachs United States 6 212 0.7× 47 0.4× 120 1.5× 75 1.1× 54 0.9× 8 336
Jeffrey Fischer United States 6 285 1.0× 72 0.6× 203 2.5× 83 1.2× 39 0.6× 6 424
Megan Wardrop United States 6 190 0.7× 52 0.5× 56 0.7× 35 0.5× 25 0.4× 7 258
Alexandre Duarte Gigante Brazil 9 291 1.0× 67 0.6× 62 0.8× 48 0.7× 44 0.7× 12 412
Michael P. Froimowitz United States 6 154 0.5× 64 0.6× 218 2.7× 118 1.8× 24 0.4× 6 569

Countries citing papers authored by Sheila Asghar

Since Specialization
Citations

This map shows the geographic impact of Sheila Asghar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila Asghar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila Asghar more than expected).

Fields of papers citing papers by Sheila Asghar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila Asghar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila Asghar. The network helps show where Sheila Asghar may publish in the future.

Co-authorship network of co-authors of Sheila Asghar

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila Asghar. A scholar is included among the top collaborators of Sheila Asghar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila Asghar. Sheila Asghar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Bhat, Ramachandra, et al.. (2022). Hypoxic–Ischemic Encephalopathy: To Cool, or Not to Cool, That Is the Question. 1(3). 320–326.
4.
Walser, Sarah A., et al.. (2020). A Comprehensive Review of Neurologic Manifestations of COVID-19 and Management of Pre-existing Neurologic Disorders in Children. Journal of Child Neurology. 36(4). 324–330. 22 indexed citations
5.
Asghar, Sheila, et al.. (2018). DNM1 Mutation in a child associated with progressive bilateral mesial temporal sclerosis. Clinical Case Reports. 6(11). 2037–2039. 8 indexed citations
6.
Asghar, Sheila, et al.. (2018). Spinal cord lesions in a pediatric patient with chronic kidney disease and review of literature: Questions. Pediatric Nephrology. 34(6). 1033–1033. 1 indexed citations
7.
Asghar, Sheila, et al.. (2018). Spinal cord lesions in a pediatric patient with chronic kidney disease and review of literature: Answers. Pediatric Nephrology. 34(6). 1035–1036. 1 indexed citations
8.
Kumar, Ashutosh, et al.. (2018). Unique presentation of rapidly fluctuating symptoms in a child with congenital myasthenic syndrome due to RAPSN mutation. Muscle & Nerve. 58(4). E23–E24. 2 indexed citations
9.
Asghar, Sheila, et al.. (2012). Variable Manifestations of Familial Hemiplegic Migraine Associated With Reversible Cerebral Edema in Children. Pediatric Neurology. 47(3). 201–204. 17 indexed citations
10.
Bell, Emily C., Morgan Willson, Alan H. Wilman, et al.. (2005). Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation. Human Psychopharmacology Clinical and Experimental. 20(2). 87–96. 26 indexed citations
11.
Willson, Morgan, et al.. (2005). Valproate attenuates dextroamphetamine-induced subjective changes more than lithium. European Neuropsychopharmacology. 15(6). 633–639. 10 indexed citations
12.
Wu, Ren, Tina O'Donnell, Michele Ulrich, et al.. (2004). Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate. PubMed. 3(1). 13–13. 34 indexed citations
13.
Willson, Morgan, Alan H. Wilman, Emily C. Bell, Sheila Asghar, & Peter H. Silverstone. (2004). Dextroamphetamine causes a change in regional brain activity in vivo during cognitive tasks: A functional magnetic resonance imaging study of blood oxygen level-dependent response. Biological Psychiatry. 56(4). 284–291. 23 indexed citations
14.
Silverstone, Peter H., Sheila Asghar, Tina O'Donnell, Michele Ulrich, & Christopher C. Hanstock. (2004). Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients. The World Journal of Biological Psychiatry. 5(1). 38–44. 20 indexed citations
15.
Asghar, Sheila, et al.. (2003). Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers. Human Psychopharmacology Clinical and Experimental. 18(4). 291–299. 57 indexed citations
16.
Silverstone, Peter H., et al.. (2003). Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. International Clinical Psychopharmacology. 18(2). 73–79. 107 indexed citations
17.
Ulrich, Michele, Susan Rotzinger, Sheila Asghar, et al.. (2003). Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels.. PubMed. 28(2). 115–25. 10 indexed citations
18.
Silverstone, Peter H., Ren Wu, Tina O'Donnell, et al.. (2002). Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Human Psychopharmacology Clinical and Experimental. 17(7). 321–327. 60 indexed citations
19.
Silverstone, Peter H., Tina O'Donnell, Michele Ulrich, Sheila Asghar, & Christopher C. Hanstock. (2002). Dextro‐amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study. Human Psychopharmacology Clinical and Experimental. 17(8). 425–429. 13 indexed citations
20.
Asghar, Sheila, Glen B. Baker, Gail Rauw, & Peter H. Silverstone. (2001). A rapid method of determining amphetamine in plasma samples using pentafluorobenzenesulfonyl chloride and electron-capture gas chromatography. Journal of Pharmacological and Toxicological Methods. 46(2). 111–115. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juliana Usher Breakdown of academic impact, for papers by Helen E. Courvoisie Breakdown of academic impact, for papers by Marie Raffin Breakdown of academic impact, for papers by Joseph M. Bebchuk Breakdown of academic impact, for papers by Kristina Hunter Breakdown of academic impact, for papers by Nadia Sachs Breakdown of academic impact, for papers by Jeffrey Fischer Breakdown of academic impact, for papers by Megan Wardrop Breakdown of academic impact, for papers by Alexandre Duarte Gigante Breakdown of academic impact, for papers by Michael P. Froimowitz
Rankless by CCL
2026